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the peritoneal tissue of experimental animals yielded similarDipyridamole inhibits human peritoneal mesothelial cell prolif-
results.eration in vitro and attenuates rat peritoneal fibrosis in vivo.
Conclusions. This study suggests that dipyridamole mayBackground. Peritoneal fibrosis (PF) is one of the most seri-
have therapeutic potential in treating peritoneal fibrosis.ous complications after long-term continuous ambulatory peri-
toneal dialysis (CAPD). Proliferation of human peritoneal meso-
thelial cells (HPMC) and matrix over-production are regarded
as the main processes predisposing to PF. Dipyridamole (DP)
Continuous ambulatory peritoneal dialysis (CAPD)has been reported to have potential as an antiproliferative
has gained increasing popularity in the treatment of ure-and antifibrotic agent. We thus investigated the effect of DP in
inhibiting proliferation and collagen synthesis of HPMC. A rat mia, and peritoneal fibrosis (PF) is one of the most seri-
model of peritonitis-induced PF was also established to demon- ous complications after long-term CAPD [1]. It had been
strate the in vivo preventive effect of DP. postulated that proliferation of human peritoneal meso-Methods. HPMC was cultured from human omentum by an
thelial cells (HPMC) accompanied by matrix expansionenzyme digestion method. Cell proliferation was measured by
the methyltetrazolium assay. Intracellular cAMP was measured plays a fundamental role in the pathogenic process of
using an enzyme immunoassay (EIA) kit. Total collagen syn- PF [2]. Pharmacological interventions that can inhibit
thesis was measured by 3H-proline incorporation assay. Expres- the proliferation of HPMC and/or matrix formation thus
sion of collagen a1 (I) and collagen a1 (III) mRNAs was deter-
may be beneficial for the prevention or retardation ofmined by Northern blotting. The rat model of peritonitis-induced
the progression of PF.PF was developed by adding dextran microbeads (Cytodex,
8 mg/1 mL volume) to a standardized suspension (3 3 109) of Dipyridamole (DP; 2,6-bis[diethanolamino]-4,8-dipi-
Staphylococcus aureus. DP was administrated via intravenous peridinopyrimido-[5,4-d]-yrimidine) is an antiplatelet agent
infusion (4 mg in 1 h) daily for seven days. Macroscopic grading with an undefined mechanism of action [3]. In additionof intraperitoneal adhesions and histological analyses of perito-
to its antiplatelet activity, DP has been shown to exertneal thickness and collagen expression were performed.
antiproliferative effects on rat vascular smooth muscleResults. Addition of DP to HPMC cultures suppressed se-
rum-stimulated cell proliferation and collagen synthesis. The cells [4] and human mesangial cells [5]. We have pre-
antimitogenic and antifibrotic effects of DP appear to be pre- viously shown that DP exerts an antifibrogenic effect on
dominantly mediated through the cAMP pathway, as DP in- rat mesangial cells by inhibiting cell proliferation andcreased intracellular cAMP in a dose-dependent manner. The
reduce cell expression of type I collagen mRNA [6].macroscopic grade of intraperitoneal adhesion and peritoneal
However, the inhibitory effect of DP on HPMC prolifer-thickness were both significantly increased in animals treated
with Cytodex plus S. aureus; on the other hand, DP attenuated ation has never been reported. Accordingly, the first
these fibrotic changes with statistical significance (P , 0.01). aim of the present study was to investigate in vitro the
Analysis of gene expression of collagen a1 (I) and a1 (III) in
inhibitory effect of DP on HPMC proliferation and colla-
gen accumulation.
The importance of bacterial peritonitis as a leadingKey words: mesothelial cell, collagen, animal model, CAPD, mitogen-
esis, cAMP, uremia, extracellular matrix. etiological agent of PF in long-term CAPD patients is
well established [7]. Several studies have demonstrated
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by Calame et al [8]; however, their infection model was HPMC were identified by the presence of vimentin and
less severe than ours and no study has focused specifically cytokeratin without desmin or factor VIII-related anti-
on the pathogenesis of PF. Another rat model of PF gen using the immunofluorescence method. All experi-
induced by Escherichia coli has also been postulated [9]. ments were performed in cells from passages 1 to 3.
Nevertheless, such infection is rare in the CAPD popula-
Cell proliferation assaytion and the induction of PF was not successful. There-
fore, we sought to establish a model that more closely A modified MTT assay was used to evaluate PMC
mimicked peritonitis-related PF in CAPD patients. The proliferation as previously reported [10]. The amount of
second aim of our work was to establish a rat model of MTT uptake (absorbance at 570 nm) by HPMC was
PF developed secondary to S. aureus peritonitis. The found to vary linearly with cell numbers ranging from
third aim was to demonstrate the in vivo preventive 4000 cells/well to 12.8 3 104 cells/well in 96-well plates
effect of DP on this experimental PF rat model. [10]. We loaded 5000 cells/well for each MTT assay. Cells
growing in the log phase were trypsinized and plated
down in 96-well plates with RPMI-1640 medium con-METHODS
taining 10% FCS. Various concentrations of treating
Materials agents were added after overnight plating. The medium
Fetal calf serum (FCS) was obtained from Biochrome and drug were changed every three days. After addi-
KG (Berlin, Germany). Culture flasks and plates were tional incubations of 24 to 120 hours, 20 mL MTT solution
purchased from Corning (Corning, NY, USA) and pre- (5 mg/mL in PBS) was added to the culture medium.
coated with 1.6 mg/cm2 of Vitrogen 100t (Celtrix Lab, Palo Cells were incubated further at 378C for four hours,
Alto, CA, USA) before cell loading. Trypsin-ethylenedi- after which the medium was replaced by 100 mL ethanol.
aminetetraacetic acid (EDTA), RPMI-1640 medium, glu- Absorbance at the reference wavelength of 630 nm and
tamine, and trypan blue were obtained from Gibco (Grand test wavelength of 570 nm was measured by an enzyme-
Island, NY, USA). Bovine serum albumin (BSA), 3-[4,5- linked immunosorbent assay (ELISA) reader. All sam-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide ples were tested in pentaplicate. The inhibition of HPMC
(MTT), 3-isobutyl-1-methylxanthine (IBMX) and other growth was calculated as follows [10]:
tissue culture reagents were purchased from Sigma (St.
Percentage of inhibition 5 1Louis, MO, USA). 3H-proline was purchased from Du-
Pont NEN (Boston, MA, USA). The enzyme immunoas-
2
Absorbance of (test well 2 initial plating)
Absorbance of (control 2 initial plating)
3 100%say (EIA) kits for cyclic adenosine monophosphate
(cAMP) were obtained from Cayman Chemical (Ann
Arbor, MI, USA). Human collagen a1 (I) and collagen Intracellular cyclic-AMP assay
a1 (III) cDNAs were purchased from American Type
We loaded 3 3 105 HPMC cells/well into a six-wellCulture Collection (Rockville, MD, USA). Agents used
plate with RPMI-1640 medium containing 10% FCS.to isolate the total RNA and Northern blot analysis were
After cells became subconfluent, they were washed twiceobtained from Boehringer Mannheim (Mannheim, Ger-
with warm RPMI-1640 medium and then mixed withmany) unless otherwise specified. DP was generously
various concentrations of agents. After five minutes ofprovided by Boehringer Ingelheim (Ingelheim, Ger-
incubation, the supernatants were discarded and ice-coldmany). All other chemicals used were of analytical grade.
95% methanol was added to each well. After 30 minutes
of incubation at 48C, the supernatants evaporated andHuman peritoneal mesothelial cell culture
cAMP was measured using EIA kits. The cells in wellsSpecimens of human omentum were obtained from
were lysed by 0.1 N NaOH and protein content was mea-abdominal surgical procedures for elective gastric cancer
sured by bicinchoninic acid assay, using BSA as a standardresection and the omentum was essentially normal. The
[12]. All experiments were performed four times.HPMC culture was carried out as we previously reported
[10, 11]. Briefly, the surgically removed human omentum
Assay of total collagen synthesiswas washed three times with PBS and then digested with
A 3H-proline incorporation assay was used to measuretrypsin EDTA (0.125%) for 15 minutes. After centrifu-
total collagen production, as we previously describedgation, the cell pellet was washed with culture medium
[11]. Briefly, HPMC were seeded in 96-well plates at aand then seeded into a vitrogen-coated (1 mg/mL) flask.
density of 2.5 3 104 cells/well in 200 mL RPMI-mediumThe medium was changed on the third day. RPMI-1640
supplemented with 10% FCS. After 48 hours, cells be-medium containing 20% FCS, penicillin (100 U/mL),
came confluent. Then the medium was replaced withstreptomycin (100 mg/mL), and insulin (30 mg/mL) was
ascorbic acid (50 mg/mL) in the presence of various con-used. After two to four days, the cells became confluent
and were subcultured with medium containing 10% FCS. centrations of DP. After incubation for another 48 hours,
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cells were labeled with 0.5 mCi of 3H-proline (100 Ci/ strain ATCC 25923 (American Type and Culture Collec-
tion, MD, USA) was used throughout the study. Beforemmol) and 50 mg/mL b-aminopropionitrile during the
final 24 hours of incubation. 3H-proline incorporation each experiment, a fresh six to nine hour culture in a
brain-heart infusion broth (BHI, Oxoid, Basingstoke,into pepsin-resistant, salt-precipitated collagen was mea-
sured with a liquid scintillation counter. The cell numbers UK) was made in an agitated water bath at 378C. Serial
dilutions were prepared and plated to determine thewere determined simultaneously by MTT assay in identi-
cally treated microplates. The results were expressed as actual inoculum sizes used. To enhance local bacterial
infection in the rat peritoneal cavity, dextran beads (Cyto-disintegrations per minute (dpm) of 3H-proline per 104
cells and were compared to the control values. All experi- dex; Sigma Chemicals, St. Louis, MO, USA) were added
to the bacterial suspension for inoculation as describedments were performed in triplicate.
by Ford et al [14]. Beads were first prepared as a stock
Northern blot analysis solution by suspending 1 g in 50 mL of PBS, and were
autoclaved before use. Aliquots of the Cytodex suspen-To determine the effect of DP on collagen gene ex-
pression, HPMC were grown in RPMI supplemented sion were added to the broth with or without bacteria
(3 3 109 CFU), and then additional broth was added forwith 10% FCS until subconfluency. HPMC were then
treated with fresh medium in the absence or presence a final volume of 1 mL for the inoculation. Rats were
divided into groups, tagged, and given an intraperitonealof various concentrations of DP. At indicated time inter-
vals, cells were harvested for isolation of total RNA, (IP) injection of the prepared suspension with a 1 mL
tuberculin syringe.as previously described [11]. The concentration of each
sample was determined using spectrophotometry with Pilot study to establish the experimental protocol. In
a pilot experiment, 30 rats were used to establish thethe absorbance at 260 nm (A260). The purity of each
sample was determined based on the ratio of A260 to A280. experimental model of peritonitis and induction of PF.
To examine the toxicity of Cytodex, six rats that hadTen micrograms of RNA were electrophoresed on a 1%
agarose gel containing 1 mol/L formaldehyde in MOPS received IP injections of various volumes and concentra-
tions of Cytodex suspension were observed for 72 hours.buffer (0.2 mol/L morpholinopropanesulfonic acid, 0.05
mol/L Na acetate, 0.01 mol/L EDTA). Equivalency of Another six rats received continuous intravenous infusion
(IVF) of DP (4 mg in 1 hour) via a jugular vein catheter,sample loading and lack of degradation were verified by
ethidium bromide staining of the 28 S and 18 S rRNA which did not produce side effects. During the observa-
tion period, all rats were active and no deaths were re-bands. The RNA then was transferred to nylon mem-
branes by overnight capillary action and followed by corded. After being anesthetized with ketamine [75 mg/kg
body weight intramuscularly (IM)], 18 rats received IPfixation in a UV cross-linker.
Because HPMCs mainly express type I and III colla- injections of various combinations of bacteria and Cyto-
dex suspension solution. After this procedure, these ani-gens [13], both of these were used as probes for Northern
blotting. A 1.5-kb EcoRI fragment of collagen a1 (I) mals were randomly allocated into two experimental
groups, and were either left without further treatmentand a 0.7-kb HindIII/EcoRI fragment of collagen a1 (III)
were subcloned, respectively, into pBSII/SK (Stratagene, or treated daily with IVF of DP through implanted jugu-
lar vein catheters. Through these pilot experiments, weLa Jolla, CA, USA) and used as templates for in vitro
transcription of antisense digoxigenin-conjugated ribo- expected to successfully induce a peritonitis-related PF.
The induced peritonitis in rats was to be serious enoughprobes (Boehringer Mannheim) according to the manu-
facturer’s instructions. The blots were developed using to cause the subsequent development of PF but not
death. Based on the results of the pilot experiments, theCSPD (Boehringer Mannheim) as the substrate for alka-
line phosphatase, as described by the supplier. The signal experimental design for the in vivo animal study was
adapted as described in the next section.intensity recorded on x-ray film was then quantified with
computerized densitometry and normalized against the Experimental design. In each experiment, rats were
divided into four groups of 10 rats per group. Group 1signal of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) messages. received IP injections of bacteria (3 3 109 CFU) only,
group 2 received Cytodex (8 mg/1 mL volume) only,
Animal model group 3 received bacteria mixed with Cytodex (3 3 109
CFU bacteria plus 8 mg Cytodex in a total volume ofAnimals. Male Wistar rats (weighing 180 to 200 g;
Simonson Lab., Gilroy, CA, USA) were maintained on 1 mL), and group 4 received the same manipulation as
group 3 except with an additional daily IVF of DP (4 mga 12-hour light/dark cycle and provided with food and
water ad libitum. All work was carried out in accordance in 60 min) for seven days. The experiment was completed
on day eight. Ten additional healthy rats that receivedwith American Association for Accreditation for Labo-
ratory Animal Care (AAALAC) regulations. IP injections of 1 mL 0.9% saline were used as the control
group.Preparation and induction of peritonitis. The S. aureus
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Morphological and histochemical analysis of the
peritoneal cavity
Gross adhesion scoring system. After anesthesia, the
rat abdomen was completely opened for an objective
observer to assess the adhesions. For this purpose, a
scale developed by Mullarniemi et al was applied with
modifications [15]. A score of 0 indicated no adhesion,
1 indicated one to three separate adhesions, 2 indicated
three or more distinctly separate adhesions, and 3 indi-
cated diffuse, sheet-like adhesions. Based on the results
of pilot experiments described earlier, we found that
adhesions may develop between the liver and omentum,
the omentum and intestinal wall, the intestine and ab-
dominal wall, or between the intestine and stomach.
Therefore, these fields were checked separately, making
12 the highest possible score. The total scores of each
rat were recorded for statistical analysis.
Histological analysis. At the time of sacrifice, perito-
neal tissue specimens were taken from the gut with the
mesentery and from the liver for histological analysis.
After being formalin fixed and paraffin embedded, tissue
was cut into 5 mm thick sections and processed using
a standard hematoxylin and eosin stain and Masson’s
Trichrome stain. The thickness of the connective tissue
between the mesothelium and the liver surface or intes-
tine wall was objectively evaluated, as previously re-
Fig. 1. Dipyridamole (DP) inhibits human peritoneal mesangial cellported [16, 17]. Each tissue section was measured at five (HPMC) growth. Time-response curve: Varying concentrations of DP
random locations. Six tissue sections per rat (3 from the were added after overnight plating of HPMC and further incubated
with 10% fetal calf serum (FCS) for one to five days. The experimentgut, 3 from the liver surface) were examined. The aver-
was repeated four times. Symbols are: (h) 10% FCS; (d) 10% FCS 1
age thickness (mm) of each tissue section was recorded 2 mg/mL DP; (j) 10% FCS 1 6 mg/mL DP; (e) 10% FCS 1 17 mg/mL
DP; *P , 0.05 and **P , 0.01, compared to 10% FCS.for statistical analysis between different groups.
Northern blot analysis of collagen content. Animals
were sacrificed, and tissue samples of the omentum, ad-
hesion strands, and the right upper quadrant of the ab-
RESULTSdominal wall were taken and then immediately frozen
In vitro studiesin an ethanol/dry ice bath and stored at 2708C. Total
RNA was extracted from homogenized tissue using Dipyridamole inhibited serum-stimulated prolifera-
TRIzol reagent (Life Technology, Grand Island, NY, tion of HPMC. Growth curve experiments were per-
USA) according to the manufacturer’s protocol. Total formed to evaluate the effect of DP on serum-stimulated
RNA (20 mg/lane) was electrophoresed on a 1% agarose/ HPMC proliferation. In time response experiments (Fig.
1 mol/L formaldehyde gel and then transferred to a nylon 1), DP at concentrations above 6 mg/mL caused a dose-
membrane. Hybridization, washing, and autoradiogra- dependent inhibition of HPMC. The dose-response study
phy were performed as described previously for North- of the effect of increasing concentrations of DP on HPMC
ern blot analysis in cultured HPMC. proliferation is shown in Figure 2. When compared to
the control group (10% FCS), growth inhibition was
Statistical analysis statistically significant (P , 0.05) starting at 6 mg/mL of
DP. The percentages of inhibition by DP at concentra-Results are expressed as mean 6 SD, unless stated
otherwise. Statistical analyses were carried out using tions of 6 and 17 mg/mL were 44% and 53%, respectively.
We therefore used a higher concentration (17 mg/mL) ofSPSS/Windows (SPSS Inc.) and StatView 4.1 (Abacus
Concept Inc., Berkeley, CA, USA) software on a per- DP in the following experiments to study its antifibrotic
effect on HPMC. To exclude the possibly toxic effect ofsonal computer. Statistical significance (P , 0.05) was
evaluated by the Student t test or one-way ANOVA such a concentration of DP on proliferative HPMC, a
cell viability test was performed using the trypan blueand modified t test with application of the Bonferroni
correction. exclusion method and by measuring the lactate dehy-
Hung et al: Dipyridamole attenuates peritoneal fibrosis2320
Fig. 3. Effect of DP (mg/mL) on intracellular cAMP levels (pmol/mg
protein) as measured by a cAMP kit. Intracellular cAMP levels were
elevated in a dose-dependent manner by DP. IBMX is 3-isobutyl-1-
methylxanthine. Data represent the mean 6 SD from three independent
experiments performed in triplicate. *P , 0.01 and **P , 0.05, relative
to control.
Fig. 2. Effect of DP on serum-stimulated HPMC proliferation. For
the dose-response study, HPMC were incubated for 120 hours after
addition of varying concentrations of DP. Data represent the mean 6
SD from three independent experiments performed in triplicate. *P ,
0.05 and **P , 0.01, compared to control.
drogenase (LDH) activity of the supernatant as we pre-
viously described [10, 11]. No differences were found in
the numbers of dead cells in the supernatant and adher-
ent HPMC fractions between control and DP-treated
wells (data not shown).
Dipyridamole increased intracellular cAMP levels
in HPMC
Dipyridamole is known to function as a phosphodies-
terase inhibitor, thereby increasing intracellular cAMP Fig. 4. Effect of DP (mg/mL) on total collagen production by HPMC.
All values were normalized by cell number (104 cells). *P , 0.05 andlevels [3, 5]. To evaluate whether DP increases intracellu-
**P , 0.01 relative to control. The experiment was repeated four timeslar cAMP levels in HPMC, we measured cAMP levels in triplicate.
after incubation of HPMC with varying concentrations
of DP (2, 6, and 17 mg/mL). In these experiments, IBMX
(1 mmol), a known phosphodiesterase inhibitor, was
26% (collagen/GAPDH ratio 1.15 vs. 0.85 for lane 1 vs.used as a positive control (Fig. 3). cAMP levels were
3). After 24 hours of incubation, DP decreased (collagen/elevated in a dose-dependent manner by DP. The addi-
GAPDH ratio 0.6 and 1.27 for lanes 4 and 5, respectively)tion of DP at concentrations of 6 and 17 mg/mL resulted
collagen a1 (I) gene expression by 55% compared within a significant increase in the intracellular cAMP levels
that treated with serum alone. We have previously dem-in HPMC. As expected, the addition of IBMX showed
onstrated a suppressive effect of collagen a1 (I) mRNAa significant increase in intracellular cAMP levels in
expression by DBcAMP (1 mmol) in cultured HPMCHPMC.
[11]. In our current study, the expression of collagen a1
Dipyridamole inhibited collagen synthesis of HPMC (III) mRNA in HPMC was also suppressed after the
addition of DBcAMP (1 mmol; data not shown).As shown in Figure 4, total collagen synthesis by
HPMC was inhibited by DP in a dose-dependent man-
In vivo studiesner. Additionally, Northern blot analysis showed that
Gross adhesion scoring system. Figure 6 shows theDP decreased collagen a1 (I) and collagen a1 (III)
results of the adhesion assessment in the different treat-mRNA levels (Fig. 5). The results of densitometry
showed that, after 12 hours of incubation, DP decreased ment groups. Group 1 (bacteria only) exhibited a mean
score of 0.9 6 0.18, which was not significantly differentserum-stimulated collagen a1 (I) mRNA expression by
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Fig. 6. Treatment of DP on adhesion formation in rats. The rat in
group 3 (Cytodex mixed with bacteria) had the highest score (meanFig. 5. Effects of DP on collagen a1 (I) and collagen a1 (III) mRNA
score 7.3 6 0.42) of adhesion ranking, and the adhesion score waslevels. Lane 1, control at zero time; lanes 2–4, treatment of cells with
significantly reduced in rats treated with DP (group 4, mean score 1.5 6DP (17 mg/mL) for 6 hours, 12 hours, and 24 hours, respectively; lane
0.43). There was no significant difference between the group that re-5, control at 24 hours.
ceived bacteria only (group 1) and the group that received Cytodex
only (group 2); the means of the adhesion scores were 0.9 6 0.18 and
0.1, respectively. *P , 0.01 compared to group 3.
from group 2 (Cytodex alone) with a mean score of 0.1.
In contrast, the rats in group 3 (Cytodex and bacteria)
had marked intraperitoneal adhesions with a mean adhe- Treatment with bacteria plus Cytodex (group 3) trig-
sion score of 7.3 6 0.42. Treatment with DP (group 4) gered a fourfold increase in connective tissue thickness
resulted in a significant reduction of the adhesion score compared to the bacteria-treated (group 1) or Cytodex-
to a mean of 1.5 6 0.43 (P , 0.01, compared to group treated rats (group 2; P , 0.01). Rats treated with DP
3). In this group, three (30%) rats were free of adhesions. (group 4) had a significantly reduced connective tissue
There was no significant difference in gross visual adhe- thickness (0.43 6 0.04) compared with that of group 3
sion scores between the control (saline only, data not rats (0.96 6 0.05; P , 0.05). These measurements re-
shown) and group 1 or 2 rats. vealed quantitative differences between groups, a result
Histological analysis. Figure 7 shows photomicro- that is similar to that obtained by using the gross visual
graphs of representative sections taken from animals adhesion scoring system (Fig. 6).
after treatment. Upon histologic examination, the nor- Northern blot analysis. Northern blot analysis was ap-
mal peritoneum consists of a single layer of mesothelial plied to detect collagen a1 (I)/a1 (III) mRNA transcripts
cells and their underlying submesothelial tissue. In the in peritoneal samples obtained from the four groups.
histology specimen of rats treated with saline alone (con- The message expressed was significantly increased in
trol), no fibrosis was observed (not shown). In compari- samples from group 3 rats (bacteria 1 Cytodex treated)
son to the control group, the fibrosis was much more compared to that of group 1 (bacteria treated) or group
prominent in group 3 rats, which had advanced gross 2 (Cytodex treated; Fig. 9). In contrast, the expression
intraperitoneal adhesions. An increased connective tis- of both genes in peritoneal tissue was suppressed by DP
sue deposit, which appeared as a thickening between the (group 4).
fragmented mesothelial layer of the peritoneum and the
liver surface, was noted (Fig. 7C). The images in Figure
DISCUSSION7 E–H are representative of different treatment groups
In vitro effectsshowing the arteries of the gut mesentery. In group 3
rats (Fig. 7G), the walls of the small arteries appeared This study demonstrated the inhibition of HPMC
much thicker than those in the other three treatment growth by DP (Figs. 2 and 3), an effect similar to what
groups; however, no increases were observed in wall we previously reported in cultured rat mesangial cells
thickness in small arteries of the gut mesentery in the [6]. DP also suppressed total collagen synthesis of HPMC
DP treated rats (Fig. 7H). Figure 8 shows a comparison in a dose-dependent manner (Fig. 5). By Northern blot-
of the mean connective tissue thickness between the ting, the present study showed that DP attenuated the
different treatment groups. Animals in groups 1 and 2 mRNA levels of collagen a1 (I) and collagen a1 (III) at
had the lowest mean value of peritoneal connective tissue 24 hours (Fig. 6). These in vitro effects of DP indicate
that it has therapeutic potential for PF in vivo.thickness, whereas group 3 rats had the highest value.
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Fig. 7. Histological assessment of fibrotic re-
action in peritoneal tissues. Representative
sections of Trichrome-Masson-stained perito-
neum displaying fibrotic thickening between
the mesothelial layer and liver surface (A–D).
Arteries of gut mesentery displaying different
magnitudes of wall thickness attributable to
fibrotic deposition in the four groups (E–H)
(original magnification 3200).
It has been suggested that DP acts as an antiplatelet inhibitor (pentoxifylline) on HPMC [18]. These data
combined indicate that the effect of DP may be throughagent by serving as a phosphodiesterase inhibitor that
increases intracellular cAMP [3, 5]. Our current study the cAMP pathway. The influence of cAMP on growth
regulation of HPMC, with a focus on cell-cycle machin-demonstrates an increase of intracellular cAMP after
DP treatment (Fig. 4), while our previous reports showed ery such as cyclin D1 and p27kip1, is currently being pur-
sued in our laboratory. We found that the inhibitorythat raised intracellular cAMP could inhibit serum-stim-
ulated HPMC proliferation and collagen synthesis [11], effects of DP and cAMP on HPMC may be through the
attenuated mitogen-activated protein kinase (MAPK)and also demonstrated that N-[2-((p-Bromocinnamyl)
amino)ethyl]-5-isoquinolinesulfonamide (H-89), a pro- activity and alterations in expressions of p27kip1 and reti-
noblastoma gene product (pRB) (unpublished data).tein kinase A (PKA) inhibitor, could reverse the antimi-
togenic and antifibrogenic effects of a phosphodiesterase The development of PF resulted mainly from an over-
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Fig. 9. Expression of collagen a1 (I) and collagen a1 (III) mRNA in
adhesion strands of (A) omentum and (B) abdominal wall tissues.
Shown are representative Northern blots performed as described in theFig. 8. Comparisons of connective tissue thickness (mm) between dif- Methods section. Both collagen a1 (I) and a1 (III) mRNA expressionsferent groups. Thickness was assessed using Trichrome-Masson’s stain were significantly increased in group 3 (rats treated with bacteria plus
(see Methods section). *P , 0.05 compared to group 3. Cytodex). In contrast, the expression of both genes was suppressed by
DP (group 4).
growth of mesothelial cells and/or the accumulation of
extracellular matrix. The dual inhibitory effects of DP a gross visual scoring system may provide a quick and
on HPMC proliferation and collagen synthesis, as dem- semiquantitative assessment of adhesion formation
onstrated in our cell culture model, form the rationale for among treatment groups [15]. The present study used
animal experiments to study DP therapy in PF induced gross observation and grading of intraperitoneal changes
subsequently to peritonitis. (Fig. 6) as well as measurement of actual connective
tissue thickness (Fig. 8) to show a suppressive effect of
In vivo effects DP on adhesion formation. Furthermore, there was a
Histological findings of PF in the peritoneum obtained good correlation between the gross observation scores
from patients [17] and experimental animals [19] are and actual connective tissue thicknesses (P , 0.01, Pear-
reportedly characterized by (1) impaired re-mesotheliali- son’s method, data not shown). Our results suggest that
zation of the peritoneum; (2) increased fibro-connective the gross observation scoring system of Mullarniemi et
tissue deposition resulting in thickening of the perito- al is convenient and as helpful as the method of actual
neum and walls of small arteries in the gut mesentery; measurement of connective tissue thickness in evaluating
and (3) the possible prevalence of inflammatory infiltra- intraperitoneal fibrosis formation [15].
tion. In our experiments, the degree of PF in rats treated Peritonitis is the main culprit for CAPD patients to
with a mixed suspension of bacteria plus Cytodex (group develop PF [20]. Experiments have shown that during
3) was prominent. Both gross development of peritoneal peritonitis, if the peritoneal fibrinolytic process is not
adhesions (Fig. 6) and connective tissue deposits (Figs. adequate, an ongoing fibrosis process will initiate, re-
7 and 8) were significantly increased. This group also sulting in the possible development of adhesions be-
demonstrated an increase in the mRNA levels of matrix tween opposing peritoneal surfaces [21]. The functional
components in peritoneal tissue samples (Fig. 9). In con- fibrinolytic activity is decreased by the severity of perito-
trast, administration of DP to diseased rats seemed to nitis and existence of foreign bodies [22]. Cytodex has
provide remarkable protection and showed (1) an almost been used as a foreign material to promote local abscess
complete suppression of peritoneal adhesions (Fig. 6); formation in experimental mice [14]. Using this foreign
(2) less thickness of connective tissue between the meso- substance, we successfully generated an easily observed
and reproducible in vivo rat model of PF. The mecha-thelium and abdominal organs (Fig. 7 A–D and 8); (3)
attenuation of increased wall thickness of small arteries nisms by which Cytodex enhances PF development in
our rat model are still not fully understood. Recently,(Fig. 7 E–H); and (4) a marked decrease in gene expres-
sion of collagen I and III in omentum and abdominal in vitro studies have provided evidence of the importance
of mesothelial cells for the balance of peritoneal proco-wall samples (Fig. 9).
There is no standard method for assessing the degree agulant and fibrinolytic activity [23]. The roles of Cyto-
dex and S. aureus on alterations in the balance of perito-of peritoneal adhesion. Measurement of connective tis-
sue thickness is the most common method for rating neal procoagulant and fibrinolytic activity deserve further
study.connective tissue deposition (fibrosis) [16]. Nevertheless,
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